Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).
Industry description
The investment seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index composed of U.S. equities in the healthcare sector.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
Market Cap
The average market capitalization across the iShares US Healthcare ETF ETF is 72.6B. The market cap for tickers in the group ranges from 366.14M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is DNA at 366.14M.
High and low price notable news
The average weekly price growth across all stocks in the iShares US Healthcare ETF ETF was -6%. For the same ETF, the average monthly price growth was -8%, and the average quarterly price growth was -2%. NTRA experienced the highest price growth at 9%, while DNA experienced the biggest fall at -25%.
Volume
The average weekly volume growth across all stocks in the iShares US Healthcare ETF ETF was 54%. For the same stocks of the ETF, the average monthly volume growth was 151% and the average quarterly volume growth was 142%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 55
P/E Growth Rating: 60
Price Growth Rating: 56
SMR Rating: 66
Profit Risk Rating: 63
Seasonality Score: 41 (-100 ... +100)